4 projets européens trouvés
Recherche sur 125080 projets européens
TERMINÉ
Control of metabolic and inflammatory pathways by nuclear receptors (NR-NET)
Date du début: 1 sept. 2013, Date de fin: 31 août 2017,
NR-NET is a multidisciplinary consortium, whose activities are directed towards the understanding of the role of Nuclear Receptors (NRs) and coregulators in metaflammatory disease. Metaflammation - metabolic disorders linked to chronic inflammation – is an emerging concept explaining the pathogenesis of a wide-spectrum of diseases. Since several nuclear receptors can directly sense metabolic alter ...
Voir le projet
11
Participants partenaires
TERMINÉ
Transposon-based, targeted ex vivo gene therapy to treat age-related macular degeneration (AMD) (TARGETAMD)
Date du début: 1 nov. 2012, Date de fin: 31 oct. 2016,
Age-related Macular Degeneration (AMD), a neurodegenerative disease of the retina, is a major cause of blindness in elderly people. Due to the aging population, AMD has been referred to as a “time bomb” in society. In the exudative form of AMD, high levels of vascular endothelial cell growth factor (VEGF) and low levels of pigment-epithelial derived factor (PEDF), an inhibitor of vascularization a ...
Voir le projet
16
Participants partenaires
TERMINÉ
Transglutaminase in disease: a novel therapeutic target? (TRANSPATH)
Date du début: 1 nov. 2011, Date de fin: 31 oct. 2015,
"TRANSPATH is a multisectorial Network designed to facilitate the exchange of knowledge and technology between 7 leading European research teams and 3 SME partners and 2 associate SME Partners involved in basic and applied research into transglutaminase (TG) related human diseases. Its ambitions are to accelerate the development of new strategies for the treatment and diagnosis of human diseases ...
Voir le projet
12
Participants partenaires
TERMINÉ
The Commercialisation of Transglutaminase (TRANSCOM)
Date du début: 1 juil. 2010, Date de fin: 30 juin 2014,
The TRANSCOM project is designed to facilitate the exchange of knowledge and technology between 3 leading European research teams and 4 SMEs each with an interest in the protein crosslinking enzymes Transglutaminases. Transglutaminases are a widely distributed group of enzymes that catalyse the post-translational modification of proteins by the formation of isopeptide bonds or by deamidation of pr ...
Voir le projet